Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B B Rasmussen

Showing results (11-20 of 84) with videos related to

Pageof 9
Sort By:
Acta Pathologica Et Microbiologica Scandinavica. Section A, Pathology|July 1, 1979
Teratogenicity of intrauterine copper wire in mice. A histopathological studyB B Rasmussen, N Christensen
Annual Review of Nutrition|August 17, 1999
Regulation of fatty acid oxidation in skeletal muscleB B Rasmussen, R R Wolfe
Journal of Applied Physiology (Bethesda, Md. : 1985)|October 24, 1997
Effect of exercise intensity on skeletal muscle malonyl-CoA and acetyl-CoA carboxylaseB B Rasmussen, W W Winder
Cancer|November 1, 1991
Prognostic indicators of metastatic bone disease in human breast cancerC Kamby, B B Rasmussen, B Kristensen
Clinical Pharmacology and Therapeutics|March 1, 1997
Imipramine demethylation in vivo: impact of CYP1A2, CYP2C19, and CYP3A4H Madsen, B B Rasmussen, K Brøsen
Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section A, Pathology|May 1, 1984
The influence of formalin and paraffin embedding on the immunohistochemical reaction of monoclonal antibodies applied to female breast tissueB B Rasmussen, J Hilgers, J Hilkens
Clinical Pharmacology and Therapeutics|October 23, 1997
Fluvoxamine inhibits the CYP2C19-catalyzed bioactivation of chloroguanideU Jeppesen, B B Rasmussen, K Brøsen
British Journal of Cancer|August 1, 1989
Oestrogen receptor status of primary breast carcinomas and their metastases. Relation to pattern of spread and survival after recurrenceC Kamby, B B Rasmussen, B Kristensen
Journal of Immunological Methods|November 5, 2013
Comparison of two direct neutralizing assay formats using recombinant follicle-stimulating hormone as agonistJ Ryding, E Hjertberg, B B Rasmussen
Pharmacology & Toxicology|December 30, 1998
Fluvoxamine is a potent inhibitor of the metabolism of caffeine in vitroB B Rasmussen, T L Nielsen, K Brøsen
Pageof 9

Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
Acta Pathologica Et Microbiologica Scandinavica. Section A, Pathology|July 1, 1979
Teratogenicity of intrauterine copper wire in mice. A histopathological studyB B Rasmussen, N Christensen
Annual Review of Nutrition|August 17, 1999
Regulation of fatty acid oxidation in skeletal muscleB B Rasmussen, R R Wolfe
Journal of Applied Physiology (Bethesda, Md. : 1985)|October 24, 1997
Effect of exercise intensity on skeletal muscle malonyl-CoA and acetyl-CoA carboxylaseB B Rasmussen, W W Winder
Cancer|November 1, 1991
Prognostic indicators of metastatic bone disease in human breast cancerC Kamby, B B Rasmussen, B Kristensen
Clinical Pharmacology and Therapeutics|March 1, 1997
Imipramine demethylation in vivo: impact of CYP1A2, CYP2C19, and CYP3A4H Madsen, B B Rasmussen, K Brøsen
Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section A, Pathology|May 1, 1984
The influence of formalin and paraffin embedding on the immunohistochemical reaction of monoclonal antibodies applied to female breast tissueB B Rasmussen, J Hilgers, J Hilkens
Clinical Pharmacology and Therapeutics|October 23, 1997
Fluvoxamine inhibits the CYP2C19-catalyzed bioactivation of chloroguanideU Jeppesen, B B Rasmussen, K Brøsen
British Journal of Cancer|August 1, 1989
Oestrogen receptor status of primary breast carcinomas and their metastases. Relation to pattern of spread and survival after recurrenceC Kamby, B B Rasmussen, B Kristensen
Journal of Immunological Methods|November 5, 2013
Comparison of two direct neutralizing assay formats using recombinant follicle-stimulating hormone as agonistJ Ryding, E Hjertberg, B B Rasmussen
Pharmacology & Toxicology|December 30, 1998
Fluvoxamine is a potent inhibitor of the metabolism of caffeine in vitroB B Rasmussen, T L Nielsen, K Brøsen
Pageof 9